The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
115126583 11512658 3 F 20150713 20160718 20150916 20160728 EXP GB-TEVA-592412ACC TEVA 79.00 YR F Y 68.00000 KG 20160728 MD GB GB

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
115126583 11512658 1 PS PREDNISOLONE. PREDNISOLONE 1 Oral 5 MILLIGRAM DAILY; 5 MG U UNKNOWN 89081 5 MG QD
115126583 11512658 2 SS PREDNISOLONE. PREDNISOLONE 1 Oral 100 MILLIGRAM DAILY; 5 MG U UNKNOWN 89081 100 MG QD
115126583 11512658 3 SS PREDNISOLONE. PREDNISOLONE 1 Oral 5 MG U UNKNOWN 89081 10 MG
115126583 11512658 4 C ACICLOVIR ACYCLOVIR 1 Unknown 600 MILLIGRAM DAILY; 87575 MG 0 200 MG TID
115126583 11512658 5 C CYCLOPHOSPHAMIDE. CYCLOPHOSPHAMIDE 1 Intravenous (not otherwise specified) 1300 MILLIGRAM DAILY; ONCE ON DAY 1 OF EVERY 21 DAY CYCLE 0 1300 MG /cycle
115126583 11512658 6 C FERROUS FUMARATE FERROUS FUMARATE 1 Oral 420 MILLIGRAM DAILY; 0 210 MG BID
115126583 11512658 7 C GLICLAZIDE GLICLAZIDE 1 Unknown 30 MILLIGRAM DAILY; 87120 MG 0 30 MG QD
115126583 11512658 8 C GRANULOCYTE-COLONY STIMULATING FACTOR FILGRASTIM 1 Subcutaneous 300 MICROGRAM DAILY; 42887.5 UG 0 300 UG QD
115126583 11512658 9 C INOTUZUMAB OZOGAMICIN INOTUZUMAB OZOGAMICIN 1 Intravenous (not otherwise specified) FORM: POWDER FOR SOLUTION FOR INJECTION; ONCE ON DAY 2 OF EVERY 21 DAY CYCLE Y UNKNOWN 0 1.4 MG POWDER FOR INJECTION /cycle
115126583 11512658 10 C INSULIN INSULIN NOS 1 Subcutaneous DOSE:18 UNIT(S) 0 QD
115126583 11512658 11 C LANSOPRAZOLE. LANSOPRAZOLE 1 Unknown 30 MILLIGRAM DAILY; 78000 MG 0 30 MG QD
115126583 11512658 12 C LISINOPRIL. LISINOPRIL 1 Unknown 20 MILLIGRAM DAILY; 61419.1666 MG 0 20 MG QD
115126583 11512658 13 C METFORMIN METFORMIN HYDROCHLORIDE 1 Unknown 1000 MILLIGRAM DAILY; 663000 MG 0 500 MG BID
115126583 11512658 14 C RITUXIMAB RITUXIMAB 1 Intravenous (not otherwise specified) ONCE ON DAY 1 OF EVERY 21 DAY CYCLE 0 700 MG /cycle
115126583 11512658 15 C THYROXINE LEVOTHYROXINE 1 Unknown 100 MICROGRAM DAILY; 307095.833 UG 0 100 UG QD
115126583 11512658 16 C TRIMETHOPRIM. TRIMETHOPRIM 1 Unknown 480 MG ONCE DAILY THREE TIMES WEEKLY 3336.19047 MG 0 480 MG Q3W
115126583 11512658 17 C SULFAMETHOXAZOLE SULFAMETHOXAZOLE 1 Unknown 480 MG ONCE DAILY THREE TIMES WEEKLY 3336.19047 MG 0 480 MG Q3W
115126583 11512658 18 C VINCRISTINE VINCRISTINE 1 Intravenous (not otherwise specified) ONCE ON DAY 1 OF EVERY 21 DAY CYCLE 0 1 MG /cycle

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
115126583 11512658 1 Diffuse large B-cell lymphoma
115126583 11512658 2 Diffuse large B-cell lymphoma
115126583 11512658 3 Diffuse large B-cell lymphoma
115126583 11512658 4 Antiviral prophylaxis
115126583 11512658 5 Diffuse large B-cell lymphoma
115126583 11512658 6 Anaemia
115126583 11512658 7 Diabetes mellitus
115126583 11512658 8 Prophylaxis
115126583 11512658 9 Diffuse large B-cell lymphoma
115126583 11512658 10 Diabetes mellitus
115126583 11512658 11 Prophylaxis
115126583 11512658 12 Hypertension
115126583 11512658 13 Diabetes mellitus
115126583 11512658 14 Diffuse large B-cell lymphoma
115126583 11512658 15 Hypothyroidism
115126583 11512658 16 Antibiotic prophylaxis
115126583 11512658 17 Antibiotic prophylaxis
115126583 11512658 18 Diffuse large B-cell lymphoma

Outcome of event

Event ID CASEID OUTC COD
115126583 11512658 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
115126583 11512658 Anaemia
115126583 11512658 Blood bilirubin
115126583 11512658 Blood creatinine increased
115126583 11512658 Confusional state
115126583 11512658 Fatigue
115126583 11512658 Insomnia
115126583 11512658 Malaise
115126583 11512658 Platelet count decreased
115126583 11512658 Pyrexia
115126583 11512658 Withdrawal syndrome

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
115126583 11512658 1 20150714 20150714 0
115126583 11512658 2 20150708 20150712 0
115126583 11512658 3 20150713 20150713 0
115126583 11512658 4 20150217 20150716 0
115126583 11512658 5 20150217 20150708 0
115126583 11512658 6 20150716 0
115126583 11512658 7 20070731 20150716 0
115126583 11512658 8 20150220 20150715 0
115126583 11512658 9 20150218 20150428 0
115126583 11512658 10 20110211 20150716 0
115126583 11512658 11 20080530 20150716 0
115126583 11512658 12 20070214 20150716 0
115126583 11512658 13 20130918 20150715 0
115126583 11512658 14 20150217 20150708 0
115126583 11512658 15 20070214 20150716 0
115126583 11512658 16 20150217 20150715 0
115126583 11512658 17 20150217 20150715 0
115126583 11512658 18 20150217 20150708 0